-+ 0.00%
-+ 0.00%
-+ 0.00%

LABCORP ANNOUNCES NATIONWIDE AVAILABILITY OF COLOSENSE®, THE FIRST FDA-APPROVED RNA-BASED AT-HOME COLORECTAL CANCER SCREENING TEST

Reuters·06/22/2026 11:00:07

Please log in to view news